BioSpace News Archive

Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Universe Pharmaceuticals INC announced that the Company received a written notification from the Nasdaq Stock Market LLC on July 15, 2022, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rules for continued listing on the Nasdaq.

July 19, 2022
·
3 min read
Business

WuXi AppTec Plans to Build a New Site in Singapore, Better Serving Global Partners and Advancing Healthcare Innovation

WuXi AppTec, a leading global provider of R&D and manufacturing services that enable the global pharmaceutical and healthcare industry, announced a plan to build a new R&D and manufacturing site in Singapore.

July 19, 2022
·
3 min read
Business

Antengene Announces Research Collaboration with Celularity to Evaluate the Potential Therapeutic Synergy of Combining Antengene’s Best-in-Class Bispecific Antibody with Celularity’s Natural Killer Cell Platform

Antengene Corporation Limited today announced that it has entered into a pre-clinical research collaboration with Celularity Inc.

July 19, 2022
·
5 min read
BioMidwest

Regenexx® Achieves Nearly Fifty (50) Percent Cost Savings by Surgery Avoidance, According to Report by Validation Institute

The Validation Institute, a third-party professional community that validates health care providers delivering superior results, has certified that patients who underwent Regenexx regenerative orthobiologic procedures to treat joint problems lower costs by avoiding surgery with excellent outcomes.

July 19, 2022
·
3 min read
Biotech Bay

Shorter wait between COVID-19 and elective surgery possible

Kaiser Permanente researchers have good news for patients, surgeons, anesthesiologists, and hospital administrators who have had to put off elective surgery because of a positive COVID-19 test.

July 19, 2022
·
4 min read
Business

WuXi Biologics Plans to Build a Comprehensive CRDMO Center in Singapore

WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization, announced a 10-year USD$1.4 billion investment plan to expand the company’s research, development, and large-scale drug substance and drug product manufacturing capacity and capabilities in Singapore.

July 19, 2022
·
3 min read
STALICLA Awarded EUR 1.7 Million to Lead Computational Drug Repositioning Activities in EU-funded REPO4EU Project

REPO4EU consortium seeks to address the urgent need for new cost-effective therapies, as well as to improve existing treatments through international cooperation, pooling research and innovation expertise.

July 19, 2022
·
2 min read
Policy

Amphastar Receives FDA Approval for Vasopressin

Amphastar Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has approved the Company’s Abbreviated New Drug Application for Vasopressin injection, USP 20 Units/mL, 1mL Single Dose Vial.

July 19, 2022
·
4 min read
Seegene launches world’s first In-life PCR campaign in Vietnam

Seegene Inc., South Korea’s leading molecular diagnostics company, will work with test center, LabHouse, to launch its In-life PCR campaign in Vietnam, for drivers of ride-hailing service Grab, starting August.

July 19, 2022
·
2 min read
Business

OneOncology Establishes Disease Groups, Appoints Chairs

OneOncology, the platform for independent community oncology practices, announced the formation of five OneOncology Disease Groups.

July 19, 2022
·
3 min read